These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Fulminant liver failure with a fatal outcome due to flutamide]. Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495 [No Abstract] [Full Text] [Related]
5. Acute hepatitis induced by cyproterone acetate. Giordano N; Nardi P; Santacroce C; Geraci S; Gennari C Ann Pharmacother; 2001 Sep; 35(9):1053-5. PubMed ID: 11573856 [TBL] [Abstract][Full Text] [Related]
17. Cyproterone acetate: hepatotoxicity and prostatic cancer treatment. Roila F; Crinò L; Carloni G; Natalini G Ann Oncol; 1993 Sep; 4(8):701. PubMed ID: 8241005 [No Abstract] [Full Text] [Related]
18. [Cyproterone acetate (Androcur-depo) in the treatment of inoperable prostatic cancer]. Stepanov VN; Goriunov VG; Chechenin MG; Sivkov AV; Gubdurakhmanov II Urol Nefrol (Mosk); 1995; (6):33-6. PubMed ID: 8686122 [TBL] [Abstract][Full Text] [Related]
19. Severe hepatitis and liver failure induced by cyproterone acetate. Murphy BJ; Collins BJ Aust N Z J Med; 1996 Oct; 26(5):724. PubMed ID: 8958378 [No Abstract] [Full Text] [Related]
20. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer]. Patel H; Rhee E; Zimmern PE J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]